COVID-19

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), spoke Thursday, Jan. 7, about the state of the COVID-19 pandemic as part of Washington University Department of Medicine’s virtual, weekly Grand Rounds. The online talk — part of the Gerald Medoff Visiting Professor Grand Rounds lecture series — was free and open to

N3C is hosting an Open House to engage CTSA members, newcomers, and the wider translational research community. The event will be kicked off with a one-hour symposium that includes opening remarks from N3C leadership, followed by a PI/Clinician Testimonial with Dr. David Ellison of OCTRI, an N3C Tutorial on how to get involved, a demonstration of the N3C Data Enclave, and flash talks from the

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is proud to share that two of our advisors have been named to the Community Advisory Board (CAB) for the National Institutes of Health Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. Robert Pearson, a member of our Participant Advisory Board (PAB), and Larisa Caicedo, a

NYU Center for the Study of Asian American Health (CSAAH) would like to share an NBC News article highlighting COVID-19 disparities among Asian subgroups: South Asian, Chinese New Yorkers among the hardest hit by Covid, study shows This article specifically highlights an important analysis of New York City Health and Hospitals (H+H) data on Asian Americans disparities in COVID, and was led by

The Irving Institute's Columbia Community Partnership for Health (CCPH), in partnership with the NYP Emergency Food Program, has been delivering groceries in upper Manhattan to 890 families each month during the COVID-19 pandemic. Watch the amazing community effort and impact that has resulted: https://vimeo.com/471555431

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

Researchers at Washington University School of Medicine in St. Louis have received a two-year, $5 million grant to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County (SSD).

In 2015 Kenneth Remy, MD, MHSc arrived in St. Louis to join the Washington University School of Medicine faculty as an assistant professor of pediatrics and launched his lab studying the intersection of transfusion hematology and immune dysregulation. He was fresh off a National Institutes of Health (NIH) fellowship in Bethesda, Maryland, gaining experience that helped to shape his future career

We hear much these days about the FDA’s decision to provide an Emergency Use Authorization for a COVID-19 vaccine. Emergency Use Authorization, or EUA, is a process by which the FDA authorizes an unapproved product to be used for serious or life-threatening conditions when there are no adequate, approved and available alternatives. This can only occur during a public health emergency. On 11 Dec

Black churches have long been strongholds for sharing trusted health information with their communities, and never has that role been more important than during the COVID-19 pandemic. A new paper details how Mayo researchers are working with Black churches in MN to address COVID-19 health disparities.

The University of Wisconsin-Madison Department of Medicine is recruiting healthcare workers for the SHIELD Study to evaluate the use of nasal and oral antisepsis to prevent COVID-19. All participation can be done remotely, so healthcare workers in a wide range of roles across the US may be eligible to participate. Compensation may be available for participants. If you have any questions or are

Working towards a cure for HIV requires many things, including tenacity, determination, and collaboration. Nilu Goonetilleke, PhD – an immunologist in the University of North Carolina School of Medicine – is well-equipped to meet this challenge. Learn more about how Goonetilleke is changing the trajectory of HIV with research support from the North Carolina Translational and Clinical Sciences (NC

Janette Goins, RN, BSN has been awarded the 2020 Dean's Performance Award for Research. Goins serves as Director of Nursing for the North Carolina Translational and Clincial Sciences (NC TraCS) Institute's Clinical and Translational Research Center (CTRC) where she has made notable contributions to research processes and innovations supporting 208 research studies from 85 faculty. NC TraCS is the

Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial. This trial is led by Johns Hopkins University. MedStar Georgetown University Hospital, MedStar Washington Hospital Center